SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Conceptus (CPTS) -- Ignore unavailable to you. Want to Upgrade?

To: telephonics who wrote (85)4/19/2008 12:06:06 PM
From: tuck  Respond to of 96
 
MRSA does not appear to be a competitor -- it's a maker of women's sweaters, and I don't know any that are FDA approved treatments for anything except perhaps chills -- and CPTS has something like $45 million and is not yet profitable. So calls for a buyback or dividend are premature.

Hallucinogens and posting don't mix.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News